Tenderwize
Back to tender search

Non-exclusive pharmaceutical discount agreement under Open-House model for Oralair(R) (ATC V01AA02)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Aug 31, 2028 · 762 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

20/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

20 / 100

Complexity

30 / 100

Risk factors

The buyer reserves the right to terminate the Open-House process early if exclusive discount agreements are concluded...

No minimum purchase volumes; actual demand depends on patient numbers, prescription behavior, and pharmacy stocking. Re...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Non-exclusive discount agreements for Oralair(R) (ATC V01AA02) under § 130a Abs. 8 SGB V
  • Supply of pharmaceutical product including parallel and re-imports
Show full summary

This is a non-exclusive pharmaceutical discount agreement under an Open-House model for the drug Oralair(R) (ATC V01AA02), organized by AOK PLUS for Saxony and Thuringia. The agreement is not a formal public procurement but a voluntary transparency notice. Any qualified pharmaceutical entrepreneur can join by submitting participation documents via the DTVP portal. The first submission deadline is August 5, 2026, with periodic deadlines thereafter. The agreement ends on August 31, 2028. No estimated value, guaranteed volumes, or award criteria are provided. The process is open but subject to confidentiality and early termination if exclusive agreements are concluded.

Risks

The buyer reserves the right to terminate the Open-House process early if exclusive discount agreements are concluded...

No minimum purchase volumes; actual demand depends on patient numbers, prescription behavior, and pharmacy stocking. Re...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG

Eligibility

  • Must submit declaration of no exclusion grounds (Eigenerklärung zum Nichtvorliegen von Ausschlussgründen)

Administrative

  • Must submit Russia sanctions declaration (Eigenerklärung Russlandsanktionen)

Requirements may be incomplete.

Buyer

Location

Erfurt, DEU

Buyer profile

Open profile

Identifier

DE256878834

Activity

Health

Lots (1)

LOT-0001

Non-exclusive pharmaceutical discount agreement under Open-House model for Oralair(R) (ATC V01AA02)

This lot covers the conclusion of non-exclusive discount agreements for the pharmaceutical product Oralair(R) (ATC V01AA02), including parallel and re-imports. The contract is under an Open-House model, with rolling submission deadlines. The agreement ends on August 31, 2028. No minimum volume or exclusivity is guaranteed.

SuppliesFrameworkEU fundedElectronic submission

Location

Dresden, Germany

Duration

Aug 2026 - Aug 2028

Category

Pharmaceutical products

Deadline

Deadline Aug 31, 2028

Procurement Details

Publication date
09 Jul 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
477144-2026

Documents (1)

Similar tenders